empower science
for patient care
The Foundation Patient & Clinical Pharmacy contributes to the promotion of clinical pharmacy in science as well as the transfer of clinical research findings into practice. The aim is to improve drug safety and patient safety for each individual patient by supporting innovative research projects.
Funding
Current Projects
Emergency Department Pharmacist​
Due to a heterogeneous patient group, parallel treatment processes and an acute lack of time, emergency departments are an environment where medication errors occur particularly frequently. In addition, 5-10% of all hospital admissions are due to adverse drug reactions - many are overlooked in the emergency department. The integration of clinical pharmacists can make a contribution to reducing such errors. While the implementation of Emergency Department Pharmacists is already established internationally and shows clear benefits for drug therapy safety, this concept is still in its infancy in Germany. In order to change this, the foundation "Patient & Klinische Pharmazie" is funding three projects that aim to establish the Emergency Department Pharmacist in German emergency departments.
​
© iStockphoto, Vitalii Petrushenko
Doctoral Program Clinical Pharmacy​
The doctoral program Clinical Pharmacy is an interdisciplinary institution at the LMU Klinikum München. The doctoral projects deal with the topic of drug therapy safety in various patient groups. The foundation Patient & Clinical Pharmacy supports research projects and the annual symposia, among other things.
​
Completed Projects
Intensive Care Pharmacist
​
Altered metabolism of drugs, complex treatment regimens and frequent therapy and dose changes in intensive care patients are risk factors for the occurrence of adverse drug reactions in intensive care units. Unlike in Germany, in many international countries the ‘Intensive Care Pharmacist’ is an integral part of the multi-professional team in intensive care units. The foundation Patient & Clinical Pharmacy supported three projects at German hospitals to establish the ‘Intensive Care Pharmacist’ in their facilities.
​
Renal Pharmacist
​
Between 20-25% of all hospitalised patients have impaired renal function and are therefore at high risk of drug-related problems (DRP). A ‘Renal Pharmacist’ can identify renal DRP through medication reconciliation and thus contribute to increasing the safety of drug therapy. However, this service is not yet standardised in Germany. The foundation Patient & Clinical Pharmacy has funded projects at four German hospitals to establish the ‘Renal Pharmacist’.
​